Characterization of apolipoprotein A-I as a potential biomarker for cholangiocarcinoma

Anderson, 2002, The Human Plasma Proteome History, Character, and Diagnostic Prospects, Molecular and Cellular Proteomics, 1, 845, 10.1074/mcp.R200007-MCP200

Aspinall, 1995, Differential expression of apolipoprotein-D and prostate specific antigen in benign and malignant prostate tissues, Journal D’urologie, 154, 622

Bondarenkoa, 2002, MALDI- and ESI-MS of the HDL apolipoproteins; new isoforms of apoA-I, II, International Journal of Mass Spectrometry, 219, 671, 10.1016/S1387-3806(02)00709-1

Brewer, 1978, The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins, Biochemical and Biophysical Research Communications, 80, 623, 10.1016/0006-291X(78)91614-5

Campbell, 1989, Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging, Radiology, 207, 41, 10.1148/radiology.207.1.9530297

Diamandis, 2002, Proteomic patterns in serum and identification of ovarian cancer, Lancet, 360, 170, 10.1016/S0140-6736(02)09390-X

Ehmann, 2007, Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling, Pancreas, 34, 205, 10.1097/01.mpa.0000250128.57026.b2

Eschera, 2006, Identification of HNP3 as a tumour marker in CD4+ and CD4− lymphocytes of patients with cutaneous T-cell lymphoma, European Journal of Cancer, 42, 249, 10.1016/j.ejca.2005.07.033

Hilario, 2003, Machine learning approaches to lung cancer prediction from mass spectra, Proteomics, 3, 1716, 10.1002/pmic.200300523

Howard, 2003, Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis, Proteomics, 3, 1720, 10.1002/pmic.200300514

Kozak, 2003, Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis, Proceedings of the National Academy of Sciences of the United States of America, 100, 12343, 10.1073/pnas.2033602100

Liotta, 2003, Clinical proteomics:written in blood, Nature, 425, 905, 10.1038/425905a

Liu, 2007, Serum Amyloid A Protein: A Potential Biomarker Correlated With Clinical Stage of Lung Cancer, Biomedical and Environmental Sciences, 20, 33

Liu, 2007, Blackwell Publishing Asia Reduced transthyretin expression in sera of lung cancer, Cancer Science, 98, 1617, 10.1111/j.1349-7006.2007.00576.x

Mahlck, 1994, Plasma prealbumin in women with epithelial ovarian carcinoma, Gynecologic and Obstetric Investigation, 37, 135, 10.1159/000292542

Malik, 2005, Serum levels of an isoform of polipoprotein A-II as a potential marker for prostate cancer, Clinical Cancer Research, 1, 1073, 10.1158/1078-0432.1073.11.3

Moore, 2006, Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population, Cancer Epidemiology, Biomarkers and Prevention, 15, 1641, 10.1158/1055-9965.EPI-05-0980

Nehls, 2004, Serum and bile markers for cholangiocarcinoma, Seminars in Liver Disease, 24, 139, 10.1055/s-2004-828891

Patel, 2006, Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Nature Clinical Practice. Gastroenterology and Hepatology, 3, 33, 10.1038/ncpgasthep0389

Petricoin, 2002, Use of proteomic patterns in serum to identify ovarian cancer, Lancet, 359, 572, 10.1016/S0140-6736(02)07746-2

Recalde, 1998, Apo A-I Zaragoza(L144R): a novel mutation in the apolipoprotein A-I gene associated with familial hypoalphalipoproteinemia, Human Mutation, 11, 416

Scarlett, 2006, Proteomic profiling of cholangiocarcinoma:Diagnostic potential of SELDI-TOF-MS in malignant bile duct stricture, 44, 658

Schmitz, 1983, Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-I) with high density lipoproteins, Proceedings of the National Academy of Sciences of the United States of America, 80, 6081, 10.1073/pnas.80.19.6081

Shaib, 2004, The epidemiology of cholangiocarcinoma, Seminars in Liver Disease, 24, 115, 10.1055/s-2004-828889

Soutar, 1992, Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis, Proceedings of the National Academy of Sciences of the United States of America, 89, 7389, 10.1073/pnas.89.16.7389

Thompson, 2004, Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter, The New England Journal of Medicine, 350, 39, 10.1056/NEJMoa031918

Yip, 2005, Protein chip array profiling analysis in patients with severe acute respirator syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia, Clinical Chemistry, 51, 47, 10.1373/clinchem.2004.031229

Yip, 2002, SELDI ProteinChip array in oncoproteomic research, Technology in Cancer Research and Treatment, 1, 273, 10.1177/153303460200100408

Yui, 1988, Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I, Journal of Clinical Investigation, 82, 803, 10.1172/JCI113682

Zhang, 2004, Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer, Cancer Research, 64, 5882, 10.1158/0008-5472.CAN-04-0746